Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antidepressant
|
| gptkbp:ATCCode |
N06AB
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
Sentia Medical Sciences
|
| gptkbp:intendedUse |
treatment of major depressive disorder
|
| gptkbp:mechanismOfAction |
serotonin reuptake inhibition
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
gptkb:investigational_drug
|
| gptkbp:bfsParent |
gptkb:Senti_Biosciences
gptkb:Senti_Biosciences,_Inc. |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
SENTI-202
|